---
title: "Suraj Cropsciences Ltd (SURAJCROP) — Share Price, Financials & Analysis"
symbol: "SURAJCROP"
company: "Suraj Cropsciences Ltd"
canonical: "https://tapetide.com/stocks/SURAJCROP"
generated_at: "2026-10-13T11:02:00.185Z"
---

# Suraj Cropsciences Ltd (SURAJCROP)

Canonical page: https://tapetide.com/stocks/SURAJCROP

## Company

- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## About

Suraj Cropsciences Limited is leading Biotech Company engaged in developing, producing, processing, packing and marketing high yielding improved seeds of hybrids and varieties of field and vegetable crops. Suraj Cropsciences has multitude of activities which includes plant breeding research and hybrid seed development, genetic enhancement research, seed production, processing, packaging marketing and consumer services.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Company has a low return on equity of 7.66% over last 3 years.
- Company has high debtors of 161 days.

## Growth Rates

| Metric | 1Y | 3Y |
| --- | --- | --- |
| net income growth | 106% | 49% |
| revenue growth | 26% | 66% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- |
| Sales | 7.4 | 18.08 | 26.72 | 33.58 |
| Expenses | 6.94 | 16.86 | 24.23 | 30.41 |
| Operating Profit | 0.46 | 1.22 | 2.49 | 3.17 |
| OPM % | 6.22 | 6.75 | 9.32 | 9.44 |
| Other Income | 0.03 | 0.08 | 0.12 | 0.14 |
| Interest | 0.3 | 0.8 | 1.79 | 2.18 |
| Depreciation | 0.07 | 0.18 | 0.59 | 0.66 |
| Profit before tax | 0.12 | 0.32 | 0.23 | 0.47 |
| Tax % | 16.67 | 28.12 | 34.78 | 31.91 |
| Net Profit | 0.1 | 0.23 | 0.16 | 0.33 |
| EPS in Rs | 0.8 | 0.77 | 0.53 | 1.1 |
| Dividend Payout % | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- |
| Equity Capital | 1.25 | 3 | 3 | 3 |
| Reserves | 0.11 | 0.33 | 0.49 | 0.81 |
| Borrowings | 4.33 | 13.28 | 19.44 | 26.46 |
| Other Liabilities | 2.57 | 5.25 | 9.62 | 9.26 |
| Total Liabilities | 8.26 | 21.86 | 32.55 | 39.53 |
| Fixed Assets | 0.48 | 4.63 | 4.26 | 3.85 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 7.78 | 17.23 | 28.29 | 35.68 |
| Total Assets | 8.26 | 21.86 | 32.55 | 39.53 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 0 | 0 | 0 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 0 |
| CFO/OP | 0 | 0 | 0 | 0 |

### Ratios

| Item | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- |
| Debtor Days | 227.88 | 171.4 | 144.93 | 161.2 |
| Inventory Days | 194.1 | 251.03 | 382.1 | 326.66 |
| Days Payable | 170.19 | 151.65 | 194.67 | 121.17 |
| Cash Conversion Cycle | 251.79 | 270.78 | 332.37 | 366.68 |
| Working Capital Days | 253.53 | 235.8 | 254.22 | 285.76 |
| ROCE % | — | 10.04 | 10.22 | 9.96 |

## Filings & Documents

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-12-01 | Credit rating update — CARE Ratings |
| 2024-10-29 | Credit rating update — CARE Ratings |
| 2023-09-05 | Credit rating update — CARE Ratings |
| 2022-07-28 | Credit rating update — CARE Ratings |
| 2021-05-27 | Credit rating update — CARE Ratings |
| 2020-05-07 | Credit rating update — CARE Ratings |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:02:00.185Z.